The role of immunohistochemistry in the Muir-Torre Syndrome

Area of Science:

• Oncology
• Dermatology
• Genetics

Background:

• Muir-Torre Syndrome (MTS) is a rare autosomal dominant disorder characterized by the association of sebaceous neoplasms and at least one internal malignancy.
• MTS is linked to inherited mutations in DNA mismatch repair (MMR) genes, leading to microsatellite instability and increased cancer risk.
• Defects in MMR genes, particularly MLH1, MSH2, MSH6, and PMS2, impair DNA replication fidelity.

Observation:

• This report details a case of a patient presenting with both a sebaceous adenoma and colorectal carcinoma.
• The patient's clinical presentation met the diagnostic criteria for Muir-Torre Syndrome.
• Immunohistochemical analysis of the sebaceous adenoma was performed to investigate potential MMR gene defects.

Findings:

• The immunohistochemical analysis revealed a loss of nuclear expression for MSH2 and MSH6 proteins in the sebaceous adenoma.
• This specific protein expression pattern is indicative of a potential underlying defect in the MSH2 or MSH6 genes.
• The findings support the diagnosis of Muir-Torre Syndrome in this patient.

Implications:

• The case highlights the importance of immunohistochemistry in diagnosing Muir-Torre Syndrome, particularly when genetic testing is not immediately available.
• Early diagnosis of Muir-Torre Syndrome is crucial for timely cancer screening and management of associated malignancies.
• Understanding the molecular basis, such as MSH2/MSH6 deficiency, aids in risk stratification and genetic counseling for affected families.